2021
DOI: 10.3390/diagnostics11091643
|View full text |Cite
|
Sign up to set email alerts
|

The Potential of Lung Epithelium Specific Proteins as Biomarkers for COVID-19-Associated Lung Injury

Abstract: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection was first reported in Wuhan, China, and was declared a pandemic by the World Health Organization (WHO) on 20 March 2020. The respiratory system is the major organ system affected by COVID-19. Numerous studies have found lung abnormalities in patients with COVID-19, including shortness of breath, respiratory failure, and acute respiratory distress syndrome. The identification of lung-specific biomarkers that are easily measurable in serum wo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
8
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 14 publications
(10 citation statements)
references
References 80 publications
2
8
0
Order By: Relevance
“…PSPB levels from mild patient samples were not statistically significant relative to HC (adjusted p = 0.53). Consistent with previous reports [ 19 ], we also observed an increase in Surfactant Protein D in the severe relative to the mild infections (adjusted p = 1.39E-05) and HC samples (adjusted p = 3.07E-05). Among the severe infection patients, PSPB levels increased with age ( Fig.…”
Section: Resultssupporting
confidence: 92%
“…PSPB levels from mild patient samples were not statistically significant relative to HC (adjusted p = 0.53). Consistent with previous reports [ 19 ], we also observed an increase in Surfactant Protein D in the severe relative to the mild infections (adjusted p = 1.39E-05) and HC samples (adjusted p = 3.07E-05). Among the severe infection patients, PSPB levels increased with age ( Fig.…”
Section: Resultssupporting
confidence: 92%
“…PSPB levels from mild patient samples were not statistically significant relative to HC (adjusted p=0.53). Consistent with previous reports (19), we also observed an increase in Surfactant Protein D in the severe relative to the mild infections (adjusted p=1.39E-05) and HC samples (adjusted p= 3.07E-05). The presence of pulmonary surfactant in the plasma of severe patient populations is consistent with an ARDS presentation with increased pulmonary capillary permeability (20).…”
Section: Resultssupporting
confidence: 92%
“…ARDS severity can be assessed based on physical exam, chest X-ray, and most importantly the degree of hypoxemia as evaluated by the PaO 2 /FIO 2 ratio [46]. Circulating biomarkers such as inflammation proteins, lung endothelium as well as lung epithelium-specific proteins have been examined so far for lung injury [47,48], but none of them can provide a robust diagnostic or prognostic assessment for ARDS [49]. So far, Krebs von den Lungen-6 (KL-6), primarily secreted by type II alveolar epithelial cells, has been shown an excellent discrimination AUC value among ARDS patients in one cohort [50].…”
Section: Discussionmentioning
confidence: 99%